Endoscopic surgery for early-stage nasopharyngeal carcinoma: a justified initial option
Authors:
- 25 July 2017
- journal article
- research article
- Published by Taylor & Francis in Acta Oto-Laryngologica
- Vol. 137 (11) , 1194-1198
Abstract
Objectives: To assess the prognosis of initial endoscopic surgery in T1N0M0 and T2N0M0 staged NPC patients. Materials and methods: Between 2002 and 2016, 10 previously untreated patients with T1N0M0 or T2N0M0 staged NPC volunteered to receive endoscopic surgery followed by four courses of TPF chemotherapy. EORTC QLQ-C30 and QLQ-H&N35 were used to evaluate the QOL after treatment. Results: With the median follow-up of 30 months (range, 9 months to 128 months), the 24-month survival rate was 100% (6/6), 90% (9/10) patients were still alive and well, 20% (2/10) patients reported tumor recurrence. One died of the disease at 128 months with nasopharyngeal recurrence. Another patient who refused preoperative PET-CT had a cervical recurrence at nine months, accepted nasopharynx and neck radiation two months later and was still alive and well at 50 months. In the post-treatment questionnaires, several NPC-specific (pain, swallowing, speech, social eating, opening mouth, dry mouth, sticky saliva) QOL domains were better preserved compared with radiotherapy alone or combined chemoradiotherapy in other surveys. Conclusions: Initial endoscopic surgery combined with chemotherapy maybe justified in the hands of highly experienced surgeon in selected early-stage NPC cases and can improve their QOL. In addition, preoperative PET-CT should be included in case of possible minimal metastases.Keywords
This publication has 18 references indexed in Scilit:
- Cancer Incidence in Five Continents: Inclusion criteria, highlights from Volume X and the global status of cancer registrationInternational Journal of Cancer, 2015
- Quality of Life of Nasopharyngeal Cancer Survivors in ChinaCurrent Oncology, 2015
- Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysisThe Lancet Oncology, 2015
- Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnairesExpert Review of Anticancer Therapy, 2014
- Current Management of Nasopharyngeal CancerSeminars in Radiation Oncology, 2012
- The prevalence and prevention of nasopharyngeal carcinoma in ChinaChinese Journal of Cancer, 2011
- Treatment Outcomes After Radiotherapy Alone for Patients With Early-Stage Nasopharyngeal CarcinomaInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Testing Psychometric Properties of the Standard Chinese Version of the European Organization for Research and Treatment of Cancer Quality of Life Core Questionnaire 30 (EORTC QLQ-C30)Journal of Epidemiology, 2004
- Treatment outcome after radiotherapy alone for patients with Stage I–II nasopharyngeal carcinomaCancer, 2003
- Quality of Life in Head and Neck Cancer Patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35Journal of Clinical Oncology, 1999